# Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct

Study · id `cardio:ct-nct05709509` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05709509](<https://clinicaltrials.gov/study/NCT05709509>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05709509

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 148 participants.

## Technical summary

Registry record NCT05709509. Randomized; no masking; primary purpose treatment. Start 2022-06-01 (actual); primary completion 2023-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 148 participants (planned count; ClinicalTrials.gov record NCT05709509, source copy `cardio:ctgov-nct05709509-2023-04-11`, retrieved 2026-10-26)
- Started: 2022-06-01 (actual) (ClinicalTrials.gov record NCT05709509, source copy `cardio:ctgov-nct05709509-2023-04-11`, retrieved 2026-10-26)
- Primary completion: 2023-05-01 (anticipated) (ClinicalTrials.gov record NCT05709509, source copy `cardio:ctgov-nct05709509-2023-04-11`, retrieved 2026-10-26)
- Completion: 2023-05-01 (anticipated) (ClinicalTrials.gov record NCT05709509, source copy `cardio:ctgov-nct05709509-2023-04-11`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT05709509, source copy `cardio:ctgov-nct05709509-2023-04-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05709509-2023-04-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
- Condition: ST Elevation Myocardial Infarction
- Condition: Colchicine
- Condition: Cardiac Remodeling, Ventricular
- Intervention (Drug): Colchicine
- Intervention (Procedure): Percutaneous Coronary Intervention
- Intervention (Other): Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
- Lead sponsor: RSD dr. Soebandi
- Lead sponsor class: OTHER\_GOV
- Collaborator: Universitas Jember
- Collaborator class: UNKNOWN
- Collaborator: University of Brawijaya
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)

## Provenance

Content hash: 8699e4e663272c909e39441125391f589184c20d6b753bff0025fbbef0acc110
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
